News
ChemChina-Syngenta deal clears US review
ChemChina’s planned 43-billion-dollar takeover of Syngenta has cleared a big hurdle. The deal has received clearance from the Committee on Foreign Investment in the United States.
In addition to this clearance, the transaction’s closing is subject to anti-trust review by numerous regulators around the world. According to a release from Syngenta, both companies are working closely with the regulatory agencies involved.
The proposed transaction is expected to be completed by the end of 2016.
Add Comment